Stay updated with breaking news from Master Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Positive preliminary combination data from KOMET-007 trial of ziftomenib in NPM1-m and KMT2A-r AML, including effective mitigation of differentiation syndrome – – First patient dosed in...
– NDA submission initiated for revumenib in R/R KMT2Ar acute leukemia under RTOR – – mNPM1 final efficacy data from the Phase 1 portion of AUGMENT-101...
Major players in the pediatric clinical trials market are Medpac Inc., PPD Inc., ICON PLC., Syneos Health, QPS Holdings LLC, Pfizer Inc., IQVIA Inc.,...
In his new role as president and CEO of The Leukemia & Lymphoma Society, pediatric hematologist oncologist E. Anders Kolb, MD, aims to expand his life’s work in advancing blood cancer research and therapies for patients of all ages. But bringing new therapies to market is just the beginning of the story.
Sizzling Summer Blowout & Huge Savings at New Age Spa Institute!